ThinkstockHumana Inc. (NYSE: HUM) reported its second-quarter financial results Wednesday before the markets opened. The company had $1.67 in earnings per share (EPS) on $13.73 billion in revenue compared to Thomson Reuters…
Argus thinks the sell-off in Aetna stock following the Humana merger announcement on July 3 presents a buying opportunity.
Over the long weekend, the first move toward an acquisition was made in the health insurance industry.
Monday's top analyst upgrades, downgrades and initiations include Epizyme, Goldcorp, GoPro, Intuitive Surgical and VMware.
The U.S. Department of Justice is now said to be set to give a very close review of any of the proposed mergers of the top health insurance players in America.
Merger talks within the health insurance sector are reaching a critical point, and it appears that there will be some major moves in the very near future.
24/7 Wall St. cannot help but wonder if it is possible that one of these top health insurance companies could be left without a merger partner.
Wednesday's top analyst upgrades, downgrades and initiations include Ambarella, Cisco Systems, Frontier Communications, Marvell Technology, Yingli Green Energy and AT&T.
Monday's top analyst upgrades, downgrades and initiations Include Ambev, CTI BioPharma, Duke, Humana, Occidental Petroleum and Yelp.
Wednesday's top analyst upgrades, downgrades and initiations include American Eagle Outfitters, AOL, Boeing, Lululemon Athletica, Microsoft, ResMed and Vivint Solar.
Cowen has a long list of stocks that are out of favor at many other firms on Wall Street. These five are leaders in their respective sectors and have big dividends.
Tuesday's top analyst upgrades, downgrades and initiations seen from Wall Street research calls include GE, Gilead Sciences, Oracle, Under Armour and El Pollo Loco.
Humana reported disappointing third-quarter 2014 results before markets opened Friday morning.
Paul Ausick A new research report from the analysts at Stifel notes that the managed care organizations (MCOs) have posted solid results and raised earnings estimates, and they have been sold off.
ThinkstockBinary events are often the key element in moving a biotech or health care stock higher. Negative binary results or actions often can move shares drastically lower. We scan our 24/7 Wall…
